Please use this identifier to cite or link to this item:
|Title:||EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide||Authors:||Ang, Michelle L. T.
Zainul Rahim, Siti Z.
de Sessions, Paola Florez
Hibberd, Martin L.
|Issue Date:||2017||Source:||Ang, M. L. T., Zainul Rahim, S. Z., de Sessions, P. F., Lin, W., Koh, V., Pethe, K., et al. (2017). EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide. Frontiers in Microbiology, 8, 710-.||Series/Report no.:||Frontiers in Microbiology||Abstract:||Ethionamide (ETH) is part of the drug arsenal available to treat multi-drug resistant tuberculosis. The current paradigm of this pro-drug activation involves the mycobacterial enzyme EthA and the transcriptional repressor, EthR. However, several lines of evidence suggest the involvement of additional players. The ethA/R locus was deleted in Mycobacterium bovis BCG and three Mycobacterium tuberculosis (MTB) strains. While complete resistance to ETH was observed with BCG ethA/R KO, drug susceptibility and dose-dependent killing were retained in the ethA/R KO MTB mutants, suggesting the existence of an alternative pathway of ETH bio-activation in MTB. We further demonstrated that this alternative pathway is EthRindependent, whereby re-introduction of ethR in ethA/R KO MTB did not lead to increased resistance to ETH. Consistently, ethA KO MTB (with intact ethR expression) displayed similar ETH susceptibility profile as their ethA/R KO counterparts. To identify the alternative ETH bio-activator, spontaneous ETH-resistant mutants were obtained from ethA/R KO MTB and whole genome sequencing identified single nucleotide polymorphisms in mshA, involved in mycothiol biosynthesis and previously linked to ETH resistance. Deletion of mshA in ethA/R KO MTB led to complete ETH resistance, supporting that the role of MshA in ETH killing is EthA/R-independent. Furthermore mshA single KO MTB displayed levels of ETH resistance similar or greater than those obtained with ethA/R KO strains, supporting that mshA is as critical as ethA/R for ETH killing efficacy.||URI:||https://hdl.handle.net/10356/83568
|DOI:||10.3389/fmicb.2017.00710||Rights:||© 2017 Ang, Zainul Rahim, de Sessions, Lin, Koh, Pethe, Hibberd and Alonso. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
SBS Journal Articles
Files in This Item:
|EthAR-Independent Killing of Mycobacterium tuberculosis by Ethionamide.pdf||1.12 MB||Adobe PDF|
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.